Modalities of Renal Replacement Therapy in Pediatric Acute Kidney Injury

NCT ID: NCT01569698

Last Updated: 2021-04-15

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

TERMINATED

Total Enrollment

310 participants

Study Classification

OBSERVATIONAL

Study Start Date

2012-06-30

Study Completion Date

2019-07-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Limited prospective data is available to compare morbidity and mortality between renal replacement modalities in pediatric acute renal failure.

In the absence of clear standard of care, the choice of the extra renal replacement therapy modality is subject to clinical judgement, practical aspects, and costs.

This study will supply important data about usual modalities of pediatric acute extra renal replacement therapy and their impact on patient outcome and renal recovery. An obvious next step will be to conduct a randomized controlled trial comparing the different strategies.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

In children, there are limited data on extra renal replacement therapy. Pediatric studies are often retrospective, or often limited to specific disease processes or specific extra renal therapy. The lack of large studies including different usual modalities in pediatrics limits any formal recommendation on use in relation to patient outcomes, including renal recovery and mortality. Some of the issues that need consideration are the choice of dialysis modality (including Intermittent Hemodialysis, Continuous Renal Replacement Therapies, and Peritoneal Dialysis), the indications for and timing of dialysis intervention, the dose of dialysis and their effects on outcomes from acute kidney injury in children.

This study will supply important data about pediatric acute extra renal replacement therapy, including the epidemiology of pediatric acute kidney injury leading to extra renal replacement therapy, the variety of the treatment modalities, and their effects on the course of the disease.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Kidney Failure, Acute

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

OTHER

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

extrarenal replacement therapy

Intermittent Hemodialysis, Continuous Renal Replacement Therapies, and Peritoneal Dialysis

acute extra renal replacement therapy

Intervention Type PROCEDURE

usual modalities of pediatric acute extra renal replacement therapy : Intermittent Hemodialysis, Continuous Renal Replacement Therapies, and Peritoneal Dialysis

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

acute extra renal replacement therapy

usual modalities of pediatric acute extra renal replacement therapy : Intermittent Hemodialysis, Continuous Renal Replacement Therapies, and Peritoneal Dialysis

Intervention Type PROCEDURE

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

Non applicable.

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Age \< 18 years, including the newborn ;
* Acute kidney injury as defined by pRIFLE classification requiring extra renal replacement therapy, whatever is the method.

Exclusion Criteria

* Treatment by extra renal replacement therapy for terminal renal failure;
* History of renal transplantation;
* Extra renal replacement therapy for an inborn errors of metabolism without acute renal failure;
* Extra renal replacement therapy in the context of a drug intoxication without acute renal failure;
* Treatment by technique in MARS (Molecular Adsorbent Recirculating System);
* Modified ultrafiltration during surgery.
Maximum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Rennes University Hospital

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Theophile Gaillot, MD

Role: PRINCIPAL_INVESTIGATOR

Rennes University Hospital

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Pediatric intensive care - Centre mère enfants

Sainte-Foy, , Canada

Site Status

Pediatric intensive care -

Sherbrooke, , Canada

Site Status

Angers University Hospital

Angers, , France

Site Status

Besançon University Hospital

Besançon, , France

Site Status

Pediatry - Bordeaux University Hospital

Bordeaux, , France

Site Status

Reanimation pediatric - Morvan Hospital

Brest, , France

Site Status

Pediatry - Cote De Nacre University Hospital

Caen, , France

Site Status

Pediatric nephrology - Hôpital Couple-enfants

Grenoble, , France

Site Status

Bicêtre University Hospital

Le Kremlin-Bicêtre, , France

Site Status

Pediatry - Hopital de la Mère et de l'Enfant

Limoges, , France

Site Status

Anesthesy-Pediatric reanimation - Nord University Hospital

Marseille, , France

Site Status

Pediatric Nephrology and dianetology - Arnaud de Villeneuve Hospital

Montpellier, , France

Site Status

Pediatric reanimation - Hôpital mère-enfant

Nantes, , France

Site Status

Réanimation et Surveillance - Robert Debre Hospital

Paris, , France

Site Status

Pediatry - Reims University Hospital

Reims, , France

Site Status

Nephrology - Hôpital des enfants

Toulouse, , France

Site Status

Nephrology - Pediatric emergency - Clocheville University Hospital

Tours, , France

Site Status

Pediatric reanimation - Brabois Hospital

Vandœuvre-lès-Nancy, , France

Site Status

Groupe hospitalier Sud Reunion

Réunion, , Reunion

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Canada France Reunion

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2010-A00670-39

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Virtual Ward for Home Dialysis
NCT01912001 COMPLETED NA